In this video, I will show you how to create eye-catching and engaging custom transitions based on the object in your video.

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

A Lebanese pop star turned wanted militant has surrendered to military intelligence after 12 years on the run. Fadel Shaker had been hiding since clashes between Sunni militants and the ...

Four months into relocating its legal headquarters to Nevada, Roblox has been sued in federal court. The lawsuit alleges that the company put “profits over safety,” which led to a 12-year-old child, ...

President Trump is ramping up his threats to send the National Guard into cities across the U.S., even after a federal judge ruled against his use of troops in Los Angeles. On Tuesday, a federal judge ...

Five months after embarking on a “massive testing and research effort” to root out the cause of the nation's "autism epidemic," Robert F. Kennedy Jr. is getting ready to present his findings this ...

NEW YORK — Twice recently, the people who run Fox News were reminded of their biggest nightmare. The conservative network Newsmax’s $67 million settlement with Dominion Voting Systems over false ...

Please provide your email address to receive an email when new articles are posted on . OAC discontinuation may be reasonable in certain patients free from AF long after undergoing catheter ablation.

Roblox says that by the end of the year it will expand its age estimation program to anyone using its chat and text features. The gaming site, which hosts 112 million users daily, has been dogged by ...

The 2025 NFL season kicks off Thursday night with the reigning Super Bowl champion Philadelphia Eagles, and that means fans will almost certainly see the team’s signature play — the controversial tush ...

On Thursday, the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) goal date for Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) supplemental New Drug Application ...